These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19375142)

  • 1. Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription.
    Sato Y; Shirata N; Kudoh A; Iwahori S; Nakayama S; Murata T; Isomura H; Nishiyama Y; Tsurumi T
    Virology; 2009 May; 388(1):204-11. PubMed ID: 19375142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex.
    Sato Y; Kamura T; Shirata N; Murata T; Kudoh A; Iwahori S; Nakayama S; Isomura H; Nishiyama Y; Tsurumi T
    PLoS Pathog; 2009 Jul; 5(7):e1000530. PubMed ID: 19649319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms.
    Mauser A; Saito S; Appella E; Anderson CW; Seaman WT; Kenney S
    J Virol; 2002 Dec; 76(24):12503-12. PubMed ID: 12438576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient increases in p53-responsible gene expression at early stages of Epstein-Barr virus productive replication.
    Sato Y; Shirata N; Murata T; Nakasu S; Kudoh A; Iwahori S; Nakayama S; Chiba S; Isomura H; Kanda T; Tsurumi T
    Cell Cycle; 2010 Feb; 9(4):807-14. PubMed ID: 20139729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
    Saha A; Murakami M; Kumar P; Bajaj B; Sims K; Robertson ES
    J Virol; 2009 May; 83(9):4652-69. PubMed ID: 19244339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitination of MDM2 modulated by Epstein-Barr virus encoded latent membrane protein 1.
    Li L; Li Z; Zhou S; Xiao L; Guo L; Tao Y; Tang M; Shi Y; Li W; Yi W; Cao Y
    Virus Res; 2007 Dec; 130(1-2):275-80. PubMed ID: 17576019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription.
    Kusano S; Ikeda M
    J Biol Chem; 2019 Oct; 294(41):15104-15116. PubMed ID: 31434743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival.
    Forte E; Luftig MA
    J Virol; 2009 Mar; 83(6):2491-9. PubMed ID: 19144715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the human cytomegalovirus IE2-86 protein binds mdm2 and facilitates mdm2 degradation.
    Zhang Z; Evers DL; McCarville JF; Dantonel JC; Huong SM; Huang ES
    J Virol; 2006 Apr; 80(8):3833-43. PubMed ID: 16571800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
    Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
    Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter.
    Lavens S; Faust EA; Lu F; Jacob M; Leta M; Lieberman PM; Puré E
    J Virol; 2004 Aug; 78(16):8543-51. PubMed ID: 15280463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53.
    Kashuba E; Yurchenko M; Yenamandra SP; Snopok B; Szekely L; Bercovich B; Ciechanover A; Klein G
    Int J Cancer; 2011 Feb; 128(4):817-25. PubMed ID: 20473904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
    J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.
    Itahana K; Mao H; Jin A; Itahana Y; Clegg HV; Lindström MS; Bhat KP; Godfrey VL; Evan GI; Zhang Y
    Cancer Cell; 2007 Oct; 12(4):355-66. PubMed ID: 17936560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the histone H3 lysine 9 methyltransferase Suv39 h1 in maintaining Epsteinn-Barr virus latency in B95-8 cells.
    Imai K; Kamio N; Cueno ME; Saito Y; Inoue H; Saito I; Ochiai K
    FEBS J; 2014 May; 281(9):2148-58. PubMed ID: 24588869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.
    Zhang Q; Gutsch D; Kenney S
    Mol Cell Biol; 1994 Mar; 14(3):1929-38. PubMed ID: 8114724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
    Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
    Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.